Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The activity of the pituitary hormones (ACTH,
STH
, TTH, FSH, LH), the adrenal hormones (cortisol, aldosterone), the kidney hormone (renin), and the thyroid hormones (thyroxine tri-iodthyronine), the thyroxine binding capacity of blood proteins and the activity of the hormones of the pancreas (insulin) and the sex glands (testosterone, estradiol) were studied in 26 males suffering from
ischemic heart disease
verified by means of selective coronarography and in 20 healthy males with no atherosclerosis of the coronary arteries of the heart. Patients with
ischemic heart disease
were found to be marked by increased activity in the blood of ACTH, TTH, cortisol, aldosterone, insulin, and estradiol and reduced concentration of
STH
, thyroxine, and testosterone. These shifts in the activity of the hypothalamo-hypophyseal system and in its subordinate hormonal systems play an important role in the origin of the atherosclerotic process and assosiated
ischemic heart disease
.
...
PMID:[Hormones in ischemic heart disease with the presence of coronary atherosclerosis]. 73 79
Cardiac pains related to estrogen therapy for prostatic cancer (PC) emerged in 53% of treated patients with
ischemic heart disease
(
IHD
). The pain complaints were associated with impairment of coronary circulation in 48% of cases. This clinical condition is attributed to elevated
STH
levels and a trend to hypercorticism. In hypertensive PC patients estrogens provoked more frequent and severe headaches which occurred at initial stages of the treatment in 23% and after 1-year administration of hormones in 44% of patients. Hypertensive reactions may be caused by aldosterone and prolactin hyperproduction. Observation of the therapist and endocrinologist can help to prevent complications in
IHD
patients with PC.
...
PMID:[Changes in hormonal homeostasis and development of disorders of the cardiovascular system in patients with prostatic cancer on estrogen therapy]. 172 22
To evaluate pathogenetic link of ischemic heart dysfunction with the level of endogenic
STH
in myocardial infarction (MI) patients at different MI stages and to specify prognostic value of
STH
for MI outcomes, we examined 78 males on MI day 21-26, month 3-6 and a year later. 20 healthy males served control and 17 patients with ischemic heart diseases without MI according to coronaroventriculography (CVG) were a comparison group.
STH
was measured in all the patients with radioimmunoassay, CVG was made according to M. Judkins. We found that in patients with high level of endogenic
STH
(> 1 nm/l) within the first postmyocardial infarction month development of reparative and adaptive fibrosis continues 3 to 6 months and is more favorable. If
STH
physiological level maintains, myocardial contractility remains satisfactory for a long period. In high
STH
levels, patients with
myocardial ischemia
more frequently exhibit ventricular arrhythmia. Low
STH
blood levels lead to left ventricular dilatation, deterioration of cardiac contractility, stenotic coronary atherosclerosis, intracardiac hemodynamics and
IHD
clinical course. Lethal outcomes occur more frequently.
...
PMID:[Correlation of somatotropic hormone with post-infarction myocardial remodelling and clinical prognosis in patients with myocardial infarction]. 1141 83